Yakira Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-120,756
Closed -$1.78M 338
2024
Q1
$1.78M Buy
120,756
+66,638
+123% +$984K 0.54% 58
2023
Q4
$726K Hold
54,118
0.24% 88
2023
Q3
$667K Sell
54,118
-10,000
-16% -$123K 0.18% 100
2023
Q2
$789K Sell
64,118
-8,000
-11% -$98.4K 0.21% 102
2023
Q1
$886K Sell
72,118
-13,614
-16% -$167K 0.22% 105
2022
Q4
$982K Sell
85,732
-30,089
-26% -$345K 0.2% 129
2022
Q3
$434K Hold
115,821
0.06% 217
2022
Q2
$689K Buy
115,821
+27,138
+31% +$161K 0.11% 193
2022
Q1
$561K Buy
88,683
+15,233
+21% +$96.4K 0.08% 222
2021
Q4
$287K Buy
73,450
+12,816
+21% +$50.1K 0.04% 274
2021
Q3
$293K Hold
60,634
0.05% 248
2021
Q2
$387K Hold
60,634
0.06% 235
2021
Q1
$381K Hold
60,634
0.08% 219
2020
Q4
$418K Sell
60,634
-6,300
-9% -$43.4K 0.1% 176
2020
Q3
$268K Hold
66,934
0.08% 160
2020
Q2
$223K Hold
66,934
0.1% 106
2020
Q1
$144K Hold
66,934
0.05% 113
2019
Q4
$211K Hold
66,934
0.06% 115
2019
Q3
$301K Sell
66,934
-18,139
-21% -$81.6K 0.09% 108
2019
Q2
$405K Hold
85,073
0.08% 100
2019
Q1
$465K Hold
85,073
0.13% 85
2018
Q4
$258K Hold
85,073
0.09% 89
2018
Q3
$357K Hold
85,073
0.07% 94
2018
Q2
$329K Sell
85,073
-9,533
-10% -$36.9K 0.08% 87
2018
Q1
$599K Sell
94,606
-12,119
-11% -$76.7K 0.14% 70
2017
Q4
$861K Buy
106,725
+87,143
+445% +$703K 0.28% 51
2017
Q3
$224K Sell
19,582
-12,295
-39% -$141K 0.07% 81
2017
Q2
$311K Buy
31,877
+303
+1% +$2.96K 0.09% 82
2017
Q1
$765K Buy
+31,574
New +$765K 0.27% 61